News
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
18 Apr 24
Biotech, Equities, Large Cap, Mid Cap, Short Sellers, Broad U.S. Equity ETFs, Price Target, Travel, Top Stories, Tech, ETFs
Oncocyte Announces Partnership Agreement With Bio-Rad Laboratories On Global Launch Of Transplant Assay; Bio-Rad Expects To Make Equity Investment In Support Of Deal
11 Apr 24
News, Contracts
Bio-Rad Laboratories Says Andrew Last, Executive Vice President And COO, Is Planning To Retire By Early September Of 2024
10 Apr 24
News, Management
Citigroup Downgrades Bio-Rad Laboratories to Neutral, Lowers Price Target to $365
3 Apr 24
News, Downgrades, Price Target, Analyst Ratings
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
16 Feb 24
Analyst Color, Equities, Large Cap, Mid Cap, Broad U.S. Equity ETFs, Small Cap, Top Stories, Economics, Federal Reserve, Intraday Update, Markets, Analyst Ratings, Movers, Tech, ETFs
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Lowers Price Target to $480
16 Feb 24
News, Price Target, Analyst Ratings
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
16 Feb 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
Preview: Bio-Rad Laboratories's Earnings
14 Feb 24
Earnings
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
23 Jan 24
Large Cap, Price Target, Top Stories, Markets, Analyst Ratings
Press releases
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
11 Apr 24
Press Releases
Bio-Rad's Chief Operating Officer Andrew Last to Retire
10 Apr 24
Press Releases
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
20 Mar 24
Press Releases
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
22 Feb 24
Press Releases
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
24 Jan 24
Press Releases